159 related articles for article (PubMed ID: 14599118)
1. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
Fukuda I; Hizuka N; Takano K
Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
5. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
6. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
8. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
9. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
10. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
[TBL] [Abstract][Full Text] [Related]
11. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
Fjellestad A; Czernichow P
Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
[TBL] [Abstract][Full Text] [Related]
12. Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus.
Fjellestad-Paulsen A; Laborde K; Kindermans C; Czernichow P
Acta Paediatr; 1993 Sep; 82(9):752-7. PubMed ID: 8241672
[TBL] [Abstract][Full Text] [Related]
13. Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.
Juul KV; Bichet DG; Nørgaard JP
Endocrine; 2011 Aug; 40(1):67-74. PubMed ID: 21626284
[TBL] [Abstract][Full Text] [Related]
14. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
Tanae A; Shimizu K; Yoshida S
Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
[TBL] [Abstract][Full Text] [Related]
15. Oral desmopressin treatment of central diabetes insipidus in children.
Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
[TBL] [Abstract][Full Text] [Related]
16. Use of subcutaneous DDAVP in infants with central diabetes insipidus.
Blanco EJ; Lane AH; Aijaz N; Blumberg D; Wilson TA
J Pediatr Endocrinol Metab; 2006 Jul; 19(7):919-25. PubMed ID: 16995572
[TBL] [Abstract][Full Text] [Related]
17. Ten-year experience with DDAVP in treatment of diabetes insipidus.
Marek J; Loutocký A; Pacovský V; Zaoral M
Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
[TBL] [Abstract][Full Text] [Related]
18. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
19. Oral desmopressin in central diabetes insipidus.
Westgren U; Wittström C; Harris AS
Arch Dis Child; 1986 Mar; 61(3):247-50. PubMed ID: 3963868
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of antidiuretic response to desmopressin acetate by iontophoretic transdermal delivery in rats.
Nakakura M; Kato Y; Ito K
Biol Pharm Bull; 1997 May; 20(5):537-40. PubMed ID: 9178935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]